在实验室代谢和使用大鼠肝脏显微体识别eutylone的代谢物
Alexandre Barcia Godoi1, Natalícia de Jesus Antunes1, Leonardo Costalonga Rodrigues1
1Centro de Informação e Assistência Toxicológica (CIATox) de Campinas, Universidade Estadual de Campinas (UNICAMP), Campinas, SP 13083-859, Brazil; Departamento de Farmacologia, Faculdade de Ciências Médicas, Universidade Estadual de Campinas (UNICAMP), Campinas, SP 13083-859, Brazil.
这项研究研究了合成卡西的eutylone的体外代谢. 尤提隆具有较低的代谢稳定性,并经历I阶段和II阶段的反应,产生八种已识别的代谢物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 尤提隆是一种合成的丁和具有刺激作用的新型精神活性物质 (NPS).
- 娱乐用途和全球扣押突出需要了解eutylone的毒理特征.
- 使用肝脏显微体的体外模型对于运动评估至关重要.
研究的目的:
- 通过使用大鼠肝脏显微体 (RLM) 调查欧提隆的体外代谢.
- 为了识别和描述欧提隆的I阶段和II阶段代谢物.
- 为了确定eutylone的关键毒动力学参数.
主要方法:
- 用大鼠肝脏显微体 (RLM) 化欧提隆.
- 使用动力模型 (希尔方程) 分析代谢稳定性和代谢物产生的分析.
- 使用分析技术识别I期和II期代谢物.
主要成果:
- 尤提隆表现出低代谢稳定性,体外清除半衰期短 (2.27分钟).
- 确定了关键的动力参数,包括Vmax,S50和清除值.
- 确定了8种代谢物,其中去甲基化和O-葡萄糖化是重要的途径.
结论:
- 脱甲基化和O-葡萄糖化是eutylone的关键代谢途径.
- 确定的毒动力学参数为eutylone的安全性和毒性提供了洞察力.
- 了解eutylone代谢对于风险评估和公共健康至关重要.
更多相关视频
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
相关概念视频
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Drug Metabolism: Phase I Reactions
Drug Metabolism: Phase II Reactions
Drug Biotransformation: Overview
Phase I Oxidative Reactions: Overview
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
